Monitor next quarterly earnings for any option exercises that could cause modest dilution. The 43.6M shares reserved under the new 2026 scheme represent ~5% of outstanding shares, but no immediate issuance or dilution.
HCM drugs
HCM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $10.71entry
- T+1 · 5mo ago +0.47%α −0.31% · $10.76
- T+5 · 4mo ago +8.78%α +7.39% · $11.65
- T+20 · 4mo ago +2.80%α +3.08% · $11.01
- T+60 · 8w ago +31.37%α +26.99% · $14.07
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HUTCHMED filed a routine blocklisting six-monthly return for its share option schemes, reporting an increase of 43.6 million shares reserved for the newly adopted 2026 Share Option Scheme and a minor issuance of 7,500 shares under the 2015 scheme. This is an administrative update with no material operational or financial news.
Key Facts
- Share option balances: 2015 scheme has 45.8M shares not yet allotted; 2026 scheme has 43.6M shares not yet allotted.
- Total shares outstanding at period end: 872,335,120.
- Only 7,500 shares were issued/allotted under the 2015 scheme during the six-month period.
- The 2026 scheme was adopted at the May 12, 2026 annual general meeting and admitted on June 11, 2026.
Financial Impact
No material financial impact; administrative share reserve updates.
Risk Factors
- Potential future dilution if executives exercise share options under either scheme.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001648257-26-000043 |
| Document: hcm-20260629x6k.htm | 0001648257-26-000043 |
| Document: 0001648257-26-000043-index-headers.html | 0001648257-26-000043 |
| Document: 0001648257-26-000043-index.html | 0001648257-26-000043 |
| Document: 0001648257-26-000043.txt | 0001648257-26-000043 |
Track record
33 reports on HCM
8 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +38.35% at T+60 after the Jun 25, 2026 report. 18 of 23 went positive at some point.
Filters
- Nov 15, 20261d ago Press Release Neutral 4/10 Entry $14.90 Now $14.73 −1.14% settles Feb 12
- Nov 5, 202611d ago 6-K Bullish 5/10 Entry $14.20 Now $14.73 +3.73% settles Feb 3
- Nov 2, 202614d ago 6-K Bullish 6/10 Entry $13.27 Now $14.73 +11.00% settles Jan 29
- Nov 2, 202615d ago Press Release Bullish 6/10 Entry $13.08 Now $14.73 +12.61% settles Feb 1
- Oct 29, 202618d ago 6-K Neutral 4/10 Entry $13.59 Now $14.73 +8.39% settles Jan 27
- Oct 27, 202620d ago 6-K Neutral 2/10 Entry $13.80 Now $14.73 +6.74% settles Jan 25
- Oct 26, 202621d ago 6-K Bullish 6/10 Entry $14.27 Now $14.73 +3.22% settles Jan 22
- Oct 26, 202621d ago Press Release Bullish 7/10 Entry $14.27 Now $14.73 +3.22% settles Jan 22
- Oct 26, 202622d ago Press Release Bullish 7/10 Entry $13.80 Now $14.73 +6.74% settles Jan 25
- Oct 21, 202626d ago 6-K Bullish 7/10 Entry $14.37 Now $14.73 +2.51% settles Jan 19
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers